UPDATE: Canaccord Genuity Assumes Coverage on Cara Therapeutics (CARA) at Buy
Tweet Send to a Friend
(Updated - November 1, 2021 8:07 AM EDT)
Canaccord Genuity analyst Sumant Kulkarni assumed coverage on Cara Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Sumant Kulkarni assumed coverage on Cara Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
